Pharmacological or TRIB3-Mediated Suppression of ATF4 Transcriptional Activity Promotes Hepatoma Cell Resistance to Proteasome Inhibitor BortezomibTiit Örd(University of Eastern Finland), T. Örd(University of Eastern Finland)CancersMay 12, 202110.3390/cancers13102341Cited by 24SaveCiteExport RISWatch citationsRelated PapersGenome-wide census of ATF4 binding sites and functional profiling of trait-associated genetic variants overlapping ATF4 binding motifs|PLoS Genetics|2023|13Dissecting the polygenic basis of atherosclerosis using disease associated cell state signatures|Research Square|2022|0